InvestorsHub Logo
Followers 11
Posts 1093
Boards Moderated 0
Alias Born 02/20/2015

Re: elichen post# 344070

Friday, 09/11/2020 2:50:25 PM

Friday, September 11, 2020 2:50:25 PM

Post# of 399542
How's long's that been? Has he said that since the change in company direction?

Naz has said there have been suiters




I've already covered #2. Nobody is paying a premium for generic Adderall. Nobody.

No debt doesn't matter if you don't have worthwhile assets. We've had little to no debt for a long time and still no buyout. Know why? No valuable assets.


pipeline, incl new form of Sequestox and new tech that can be applied to any other drug to make it ADT



That pipeline has no development. Bios don't get bought for an undeveloped pipelines. Based on Nasrat's history, he might would sell the product but not the whole company, and if he sold that product, it would be for pennies or nickels.

So that takes us back to nothing worth buying. The sole hope of a buyout really rests on the presumption that Nasrat has to sell the company to get out? I think it's just as assumption that he wants to get out. Also an assumption that he has to sell if he wants out. He could just give day to day control to someone else, stay as board chairman, and keep his money parked in Elite shares.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News